StockData
CytoDyn Inc. logo

CytoDyn Inc. (CYDY) stock

CYDYOTCPharmaceutical PreparationsFiscal year ends May 31
Financials through Q1 FY2027, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 14, 2026Score 4/30
$0.25+0.02 (+9.53%)

Close on Oct 19, 2026Market cap $345.56MP/E –Yield –

CytoDyn free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

CytoDyn's free cash flow for the twelve months ending Feb 28, 2022 was -$104.54M. For fiscal 2021 it was -$117.70M. The highest annual figure on record is -$1.83M in fiscal 2011.

Annual free cash flow

PeriodPeriod endValueChange
FY2021May 31, 2021-$117.70M–
FY2020May 31, 2020-$68.85M–
FY2019May 31, 2019-$50.49M–
FY2018May 31, 2018-$29.90M–
FY2017May 31, 2017-$26.74M–
FY2016May 31, 2016-$24.82M–
FY2015May 31, 2015-$12.04M–
FY2014May 31, 2014-$7.41M–
FY2013May 31, 2013-$3.40M–
FY2011May 31, 2011-$1.83M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q3 FY2022CQ1 2022Feb 28, 2022-$11.06M–
Q2 FY2022CQ4 2021Nov 30, 2021-$28.90M–
Q1 FY2022CQ3 2021Aug 31, 2021-$31.75M–
Q4 FY2021CQ2 2021May 31, 2021-$32.83M–
Q3 FY2021CQ1 2021Feb 28, 2021-$23.67M–
Q2 FY2021CQ4 2020Nov 30, 2020-$20.19M–
Q1 FY2021CQ3 2020Aug 31, 2020-$41.01M–
Q4 FY2020CQ2 2020May 31, 2020-$29.32M–
Q3 FY2020CQ1 2020Feb 29, 2020-$17.54M–
Q2 FY2020CQ4 2019Nov 30, 2019-$6.79M–
Q1 FY2020CQ3 2019Aug 31, 2019-$15.20M–
Q4 FY2019CQ2 2019May 31, 2019-$9.54M–
Q3 FY2019CQ1 2019Feb 28, 2019-$14.76M–
Q2 FY2019CQ4 2018Nov 30, 2018-$17.22M–
Q1 FY2019CQ3 2018Aug 31, 2018-$8.97M–
Q4 FY2018CQ2 2018May 31, 2018-$6.98M–
Q4 FY2017CQ2 2017May 31, 2017-$7.17M–
Q3 FY2017CQ1 2017Feb 28, 2017-$8.80M–
Q2 FY2017CQ4 2016Nov 30, 2016-$4.51M–
Q1 FY2017CQ3 2016Aug 31, 2016-$6.26M–

More CytoDyn figures

See a number that looks wrong?